Boundless Bio, Inc. Common Stock (BOLD) — Long-term Investment Intensity
Boundless Bio, Inc. Common Stock (BOLD) has a Long-term Investment Intensity of 30.8% as of December 2021. Long-term investments of $34.99 Million represent 30.8% of total assets of $113.72 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore Boundless Bio, Inc. Common Stock operating cash flow efficiency to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Boundless Bio, Inc. Common Stock Long-term Investment Intensity (2021–2021)
This chart shows how Boundless Bio, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of December 2021, the intensity stands at 30.8%, reflecting long-term investments of $34.99 Million against total assets of $113.72 Million USD. Explore how well can Boundless Bio, Inc. Common Stock service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Boundless Bio, Inc. Common Stock (2021–2021)
The table below presents the year-by-year Long-term Investment Intensity for Boundless Bio, Inc. Common Stock from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Boundless Bio, Inc. Common Stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 30.8% | $34.99 Million | $113.72 Million | — |